Search research articles
Contact Us
Filters
Showing results (1261-1270 of 1,535) with videos related to
Page
of 154
Sort By:
Investigational New Drugs
|
April 10, 2013
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients
Douglas A Rubinson, Howard S Hochster, David P Ryan, et al.
Genes & Development
|
February 4, 2011
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer
Kim J Png, Mitsukuni Yoshida, Xiang H-F Zhang, et al.
Blood
|
April 2, 2009
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Asish K Ghosh, Tait D Shanafelt, Amelia Cimmino, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
Luc G T Morris, Barry S Taylor, Trever G Bivona, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 26, 2011
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex
June Goto, Delia M Talos, Peter Klein, et al.
Journal of Sex Research
|
April 7, 2021
Locating the Risk: Using Participatory Mapping to Contextualize Perceived HIV Risk across Geography and Social Networks among Men Who Have Sex with Men in the Deep South
Trisha Arnold, Thomas J Stopka, Courtney E S Gomillia, et al.
The Oncologist
|
August 3, 2021
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review
David L Chan, Emily K Bergsland, Jennifer A Chan, et al.
Neuro-Oncology Advances
|
January 22, 2026
IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms
Kyle M Heemskerk, Samir Assaf, Xiaoguang Hao, et al.
American Journal of Medical Genetics. Part A
|
July 31, 2025
Identification of a Second-Hit Brain Somatic DEPDC5 Variant Supports Causality of a DEPDC5 Germline Variant of Uncertain Significance. Time for a Classification Update?
Ala'a Alsayed, Zainab Hakim, Daria Merrikh, et al.
The Oncologist
|
January 21, 2025
A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors
Kimberly Perez, Matthew H Kulke, Hui Zheng, et al.
Page
of 154
Search research articles
Search
Showing results (1261-1270 of 1,535) with videos related to
Sort By:
Page
of 154
Investigational New Drugs
|
April 10, 2013
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients
Douglas A Rubinson, Howard S Hochster, David P Ryan, et al.
Genes & Development
|
February 4, 2011
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer
Kim J Png, Mitsukuni Yoshida, Xiang H-F Zhang, et al.
Blood
|
April 2, 2009
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Asish K Ghosh, Tait D Shanafelt, Amelia Cimmino, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
Luc G T Morris, Barry S Taylor, Trever G Bivona, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 26, 2011
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex
June Goto, Delia M Talos, Peter Klein, et al.
Journal of Sex Research
|
April 7, 2021
Locating the Risk: Using Participatory Mapping to Contextualize Perceived HIV Risk across Geography and Social Networks among Men Who Have Sex with Men in the Deep South
Trisha Arnold, Thomas J Stopka, Courtney E S Gomillia, et al.
The Oncologist
|
August 3, 2021
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review
David L Chan, Emily K Bergsland, Jennifer A Chan, et al.
Neuro-Oncology Advances
|
January 22, 2026
IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms
Kyle M Heemskerk, Samir Assaf, Xiaoguang Hao, et al.
American Journal of Medical Genetics. Part A
|
July 31, 2025
Identification of a Second-Hit Brain Somatic DEPDC5 Variant Supports Causality of a DEPDC5 Germline Variant of Uncertain Significance. Time for a Classification Update?
Ala'a Alsayed, Zainab Hakim, Daria Merrikh, et al.
The Oncologist
|
January 21, 2025
A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors
Kimberly Perez, Matthew H Kulke, Hui Zheng, et al.
Page
of 154